|
HS Code |
442892 |
| Product Name | 6-Bromo-4-Methoxypyrazolo[1,5-A]Pyridine |
| Cas Number | 1262668-70-7 |
| Molecular Formula | C8H6BrN3O |
| Molecular Weight | 240.06 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Solubility | Soluble in DMSO, DMF, moderate in methanol |
| Smiles | COc1cnn2cc(Br)ccc12 |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Synonyms | 6-Bromo-4-methoxy-pyrazolo[1,5-a]pyridine |
As an accredited 6-Bromo-4-Methoxypyrazolo[1,5-A]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-4-Methoxypyrazolo[1,5-A]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Anyone who has spent long hours in the lab recognizes a turning point—those rare compounds that unlock a run of syntheses previously considered out of reach. 6-Bromo-4-Methoxypyrazolo[1,5-a]pyridine stands as one of those tools, drawing attention not just for what it does on paper, but for how it actively changes the routes chemists can take. The way this compound slots into synthesis strategies tells a deeper story, reflecting decades of incremental progress in heterocyclic chemistry and how today’s researchers build upon that cumulative work.
The pyrazolo[1,5-a]pyridine backbone has emerged as a staple motif for many researchers in pharmaceuticals, agrochemicals, and material science. Attaching a bromo group at the 6-position, paired with a methoxy at the 4-position, sets up the molecule for specific tasks. From personal experience, watching a Suzuki coupling snap into action because the right bromo-substituted heterocycle was on hand brings a kind of satisfaction hard to convey to those who stick to textbook cases.
Unlike basic starting materials or trivial functional groups, the 6-bromo substitution on this heterocycle transforms its reactivity. Suzuki, Stille, and Buchwald-Hartwig reactions—techniques that fill the synthetic chemist’s toolkit—all benefit from that reactive bromo. The methoxy group offers a different flavor entirely, subtly tweaking electron density, adding selectivity, and opening possibilities for tailored physical properties. Each functional handle takes on more meaning as researchers look for ways to construct ever-more complicated architectures.
Standing at the bench, comparing options for a cross-coupling reaction, choices come down to more than what’s available. Quality, purity, and performance can separate a frustrating experiment from a publishable result. This compound demonstrates what precision manufacturing and thoughtful design bring to research: a high degree of purity (often in excess of 98%) gives confidence that side reactions won’t derail plans. Moisture, trace impurities, or subtle modifications make or break sensitive steps—anyone who has run TLC after a botched batch knows the stakes.
Where lesser intermediates force detours or improvisations to patch the chemistry, 6-Bromo-4-Methoxypyrazolo[1,5-a]pyridine often solves these headaches directly. In my own work, switching to a better grade of a problematic substrate instantly delivered higher yields and cleaner isolations, cutting hours off the purification grind. Conversations with colleagues confirmed this across many labs; the right material does more than react—it clears obstacles quietly, setting the project back on track.
As interest in nitrogen-rich heterocycles continues to grow, this compound becomes more than a curiosity. Pharmaceutical teams rely heavily on such motifs to fine-tune drug candidates’ biological activity. Here, the bromo group doesn’t just act as a placeholder; it beckons creative extension through metal-catalyzed couplings, letting medicinal chemists append groups that control solubility, metabolic stability, and target engagement. I recall reading case studies of kinase inhibitors, where strategic placement of a methoxy or halogen decided between clinical promise and failure.
In crop protection, the need for molecules that thread the needle between activity and environmental stability keeps demand high for versatile, easily modified cores. Research papers and patents point to pyrazolo[1,5-a]pyridines in new insecticides and herbicides. The bromo-methoxy combination brings both accessibility for further derivatization and useful physicochemical properties straight out of the bottle.
Many chemists have dabbled with fluorinated, chlorinated, or unsubstituted versions of similar scaffolds. The differences are more than academic. Bromine’s unique balance of reactivity and size gives it advantages in downstream reactions and biological activity compared to smaller halogens, which can be sluggish or lead to less controllable selectivity. Compared side by side with a simple 4-methoxypyrazolo[1,5-a]pyridine, the addition of bromine at the 6-position brings a crucial handle for palladium-catalyzed chemistry. If you’ve ever struggled through a multi-step sequence because your handle was wrong, the right starting material feels like a revelation.
By contrast, chlorinated and iodinated analogs have their place, but these carry trade-offs. Chlorides hang on too tight during coupling, hindering smooth transformations, while iodides, though reactive, sometimes compromise compound stability and cost. The methoxy group substitutes for bulkier alkoxy groups by offering a less intrusive electronic effect, preserving room for fine-tuning later. Over time, I’ve found that well-designed bromo-methoxy heterocycles often slot into a synthesis more easily, demand less troubleshooting, and consistently provide higher yields. This shortens discovery timelines and encourages ambitious projects that might be unthinkable with less cooperative substrates.
Sizing up a starting material, chemists immediately pay attention to ease of purification, solubility, and reproducibility. The crystalline form of 6-Bromo-4-Methoxypyrazolo[1,5-a]pyridine stores well, resists atmospheric degradation, and allows for repeated weighing without worrying about creeping decomposition. Its solubility favors common organic solvents, which is a blessing for anyone running parallel synthesis or scaling up reactions; switching solvents in midstream is one less complication.
One hurdle familiar to many is the challenge of sourcing intermediates at research and pilot scale. This molecule distinguishes itself by remaining available in both research and larger-scale quantities. Documentation supports batch-to-batch consistency, reducing surprises during process development. Feedback from process chemists echoes this: few things frustrate a project manager more than watching timelines slip because a once-reliable compound vanishes or comes with new issues. Reliable sourcing smooths communication across research, development, and production teams.
In the last decade, growing awareness of supply chain transparency has changed how researchers evaluate chemicals. Questions about provenance go beyond marketing. Chemists want assurances on responsible manufacturing practices, waste management, and environmental impact. I remember the industry-wide shift when questions about contaminants linked to poor waste disposal broke into the headlines; reputations changed overnight.
Choosing a supplier for a high-value intermediate like 6-Bromo-4-Methoxypyrazolo[1,5-a]pyridine, informed buyers now look for evidence of compliance, not just promises. Certificates of analysis mean more when they’re backed by third-party audits or clear traceability. Environmental advocates and lab safety officers now work with procurement to ensure the wider impact of new chemical introductions stays in focus. This attention to detail sometimes slows down ordering, but the result is a culture that rewards stewardship.
Years at the bench have taught chemists everywhere that no compound, however promising, answers every need. Analytical work confirms that 6-Bromo-4-Methoxypyrazolo[1,5-a]pyridine stands up to most standard handling routines. That said, scaling up from milligrams to grams or from grams to kilograms brings out differences that only emerge late in development. Early pilot batches may reveal impurities not detected at smaller scale, so process validation matters—thorough NMR, HPLC, and elemental analyses flag problems before they cascade.
Stories circulate in group meetings about unexplained side products; learning to spot when bromine is insufficiently activated, or when a methoxy group stubbornly resists displacement, becomes a skill as valuable as technique itself. In my own projects, small adjustments—alternating solvent, dialing in base or catalyst loading, running test reactions under nitrogen—resolved problems when following literature recipes failed. The compound’s robustness supports a forgiving learning curve, letting researchers climb steeper learning curves with greater confidence.
No single compound ends all headaches. Even here, a persistent issue arises with over-reliance on palladium catalysts for couplings, inviting expense and waste. Innovations in nickel catalysis and new ligands change the equation, letting chemists explore cross-coupling with more sustainable options. Continued improvement in catalyst design, solvent selection, and process intensification—continuous flow, microwave, or photochemical reactors—further enhances what researchers can do with a substrate like this.
Collaborative networks of academic and industrial partners have also begun publishing “best practice” guides. Sharing experience with impurities, batch variability, and alternative reaction protocols boosts the community as a whole. When labs document not just the successful route, but the methods that failed, everyone benefits. More suppliers are taking the cue, providing expanded technical notes, suggested protocols, and real-person technical support. This open exchange drives progress, making each new attempt at synthesis a learning opportunity, not a shot in the dark.
Seeing compounds like 6-Bromo-4-Methoxypyrazolo[1,5-a]pyridine become widely available underscores just how much the field has changed. Early in my career, sourcing advanced intermediates meant weeks of waiting, repeated batches, and frequent re-optimization. Ongoing advances in chemical manufacturing, purification, and workflow now let more labs take on ambitious synthetic projects without the burden of inventing every piece themselves.
Workshops and collaborations make it clear: these building blocks don’t just save time, they change the landscape of what’s possible. Researchers from academia, biotech start-ups, and large pharmaceutical companies now expect to work with a wider range of functionalized intermediates delivered with reliable documentation. This foundation supports faster hypothesis testing, opening the door to rapid iteration and discovery.
With every new molecule comes responsibility. Improving synthesis speed or new bioactivity matters, but so does minimizing environmental harm. Chemists, too, bear the obligation to choose, use, and dispose of intermediates with care. Encouraging recycling of solvents, adopting greener reagents, and supporting suppliers who invest in clean processes make a difference that adds up with every scale-up.
Practices that cut laboratory waste—closed transfers, efficient reaction workups, and careful planning for reagent quenching—emerge from both institutional guidelines and hard-won lab experience. I recall being mentored by more senior colleagues who impressed upon me the value of good habits when using precious or reactive intermediates. Documenting and sharing these lessons often shapes outcomes long after the reaction vials are cleaned.
I have learned to view each new compound as both an opportunity and a puzzle. For many, 6-Bromo-4-Methoxypyrazolo[1,5-a]pyridine epitomizes a shift to readily available, highly functionalized heterocycles that spark new advances in drug design and materials science. As interdisciplinary projects blur the boundaries between chemistry, biology, and engineering, the importance of reliable, thoughtfully made starting materials grows.
One need only scan recent patents, publications, or the list of approved drugs to see the fruits of this progress. What once took a specialist’s touch now belongs to a wider pool of innovators. Each reliable intermediate lowers barriers, turning bright ideas into new candidates and discoveries. The compound’s influence, like so many others emerging today, finds expression in better medicines, smarter materials, and a deeper respect for chemistry’s role in solving practical problems.
The journey from research-grade intermediate to a headline-grabbing molecule runs through careful selection of building blocks, painstaking optimization, and honest assessment at every step. Experience teaches that there’s no shortcut for attention to detail. Whether advancing a pharmaceutical lead, designing a new catalyst, or developing a safer crop protection agent, choosing robust and well-characterized intermediates underpins progress.
So, 6-Bromo-4-Methoxypyrazolo[1,5-a]pyridine offers more than a sum of its atoms. As chemistry evolves, the real impact depends on what researchers do with each opportunity these building blocks afford. In hands both experienced and new, it paves the way for tomorrow’s questions, tomorrow’s answers, and, just maybe, tomorrow’s breakthroughs.